Antifungal activities of Eugenia umbelliflora Berg. (Myrtaceae) were tested in vitro against a panel of standard and clinical isolates of human fungal pathogens (dermatophytes and opportunistic saprobes). Methanol extracts of leaves and fruits of E. umbelliflora were separately prepared and partitioned, to yield dichloromethane (DCM), ethyl acetate (EtOAc) and aqueous fractions (Aq). Three compounds (1-3) were obtained from the DCM extract using chromatographic procedures. Antifungal assays were performed using agar dilution techniques. Both extracts (fruits and leaves), their DCM and EtOAc fractions, and compound 2 (betulin and betulinic acid) presented selective antifungal activity against dermatophytes (Epidermophyton floccosum, Microsporum canis, Microsporum gypseum, Trichophyton rubrum, Trichophyton mentagrophytes), with MIC values between 200 and 1000 µg/mL, and interestingly, inhibited 4/5 species with MIC values of ≤500 µg/mL. The aqueous fractions of fruits and leaves, and compounds 1 (α, β amyrin) and 3 (taraxerol) were inactive up to the maximum concentrations tested (1000 µg/mL).
Fungal infections have shown a significant increase in recent decades as a consequence of changes in their epidemiology [1] . There are three main groups of pathogenic fungi, which are quite different from one another: dermatophytes, dimorphic saprobes and opportunistic saprobes [2a] . Dermatophytes are a group of closely related fungi that have the capacity to invade the skin, hair, and nails of humans and animals to produce an infection, dermatophytoses, commonly known as ringworm, which has become more common in recent years. Indeed, in some areas of the world it is now considered a major public health problem [2b] .
Despite the introduction of new antifungal drugs, these are limited in number. The increase of fungal resistance to classical drugs, the high cost of treatment, and the fact that most available antifungal drugs have only fungistatic activity, justify the search for new strategies [2c] . Considering this aspect, plants used in folk medicine could be a promising resource for the development and discovery of new antifungal agents for the treatment of various fungal
infections. An extensive review of antifungal activities of natural sources was recently published [3] , and medicinal plants effective against some dermatophytes have also been reported [4a-4h] . However these reports are still very few.
Eugenia umbelliflora Berg. (Myrtaceae) is known as baguaçu, guapê or guamirim in Brazil. Only a few reports of this species have been published, including some of its biological properties [5a,5b] . A previous study carried out by our group has shown that E. umbelliflora has high potential as an antibacterial agent, especially against Gram-positive bacteria [5c]. The aim of this study was to determine the antifungal activity against a panel of human fungal pathogens of the methanol extract of the species and its fractions, and of compounds isolated from its leaves and fruits.
Initially, crude methanol extracts (CME) were prepared, separately, of E. umbelliflora fruits and leaves, and three fractions (dichloromethane, ethyl acetate and aqueous) were prepared of each extract in order to determine where the possible active NPC Natural Product Communications 2009 Vol. 4 No. 9 1181 -1184 Crude extract of fruits (CE Fruits); dichloromethane fraction of fruits (DCM Fruits); ethyl acetate fraction of fruits (EtOAc Fruits); aqueous fractions of fruit (Aq. Fruits); crude extract of leaves (CE Leaves); dichloromethane fraction of leaves (DCM Leaves); ethyl acetate fraction of leaves (EtOAc Leaves); aqueous fractions of leaves (Aq. Leaves); mixture of α-and β-amyrin (1); mixture of betulin and betulinic acid (2); taraxerol (3) compounds are located. Three different compounds were isolated from the DCM fraction of the leaves: a mixture of α-, β-amyrin (1), a mixture of betulin with traces of betulinic acid (2), and taraxerol (3).
Extracts, fractions and compounds were tested for antifungal properties against a panel of human opportunistic pathogenic fungi, and the results showed that the activity varied with the fungi tested, mainly between groups of fungal dermatophytes and opportunistic saprobes.
The dermatophytes were selectively inhibited by compounds present in E. umbelliflora, with MIC values between 200 and 1000 µg/mL, and interestingly, inhibited 4 of the 5 species with MIC values of ≤500 µg/mL. In contrast, different results were obtained for the opportunistic saprobes (Aspergillus flavus, A. fumigatus, A. niger and Rhizopus sp.) and the yeasts (C. albicans, C. tropicalis and C. neoformans), for which none of the extracts, fractions or pure compounds showed activity up to 1000 µg/mL. The aqueous fractions of fruits and leaves were inactive up to the maximum concentrations tested (1000 µg/mL), suggesting that the selective principles are probably non-polar compounds ( Table 1) . Also the compounds isolated (1 and 3) were inactive up to 1000 µg/mL, suggesting that other compounds are responsible for the antifungal activity. The mixture of betulin and betulinic acid (2) produced MIC values against the dermatophytes tested ranging from 200 to 400 µg/mL. As in the mixture of betulin and betulinic acid (2) isolated from E. umbelliflora leaves the major substance was betulin, with only 10% of betulinic acid (GC data), these results are in concordance with previous studies that have demonstrated significant activity only for betulinic acid [7c,7d].
It was shown that, in general, the extract of the fruits and its fractions were more active than the extract of the leaves and its fractions. The antifungal activity demonstrated by DCM and EtOAc fractions from the fruits can be considered moderate for the majority of Antifungal activities of Eugenia umbelliflora Natural Product Communications Vol. 4 (9) 2009 1183 the fungi tested. However, the leaves extract and its fractions exhibited weak antifungal activity. This may be due to a lower concentration of the active principles in this part of the plant.
We have previously observed [5c] that the fruits exhibited greater activity than the leaves, when tested against bacteria. A similar profile was also observed in this study against fungi. However, the activity was more pronounced against bacteria than against fungi. These results are in accordance with research by other authors [8a-8c] . In conclusion, the extracts and their DCM and EtOAc fractions, particularly of the fruits of E. umbelliflora, possess important in vitro antifungal activity, denoting their potential as antidermatophytes. 1 kg) were macerated in methanol, at room temperature, for 7 days. The crude methanolic extract (CE) was concentrated under reduced pressure to obtain the MeOH crude extract (16.4% of yield). The residues were then suspended in a mixture of water: methanol (3:7) and successively partitioned with dichloromethane (DCM) and ethyl acetate (EtOAc), to yield the respective DCM and EtOAc fractions. All fractions were concentrated using a rotary vacuum evaporator to obtain the dry fractions, with yields of 0.22 % and 0.074%, respectively. The fruits were dried in circulating air at 37 o C for 2 days, and powdered using a knife grinder. The dried fruits (570 g) were extracted twice by maceration with n-hexane for 5 days. Next, the solvent was removed under vacuum to yield a dry residue of 2.62% n-hexane extract. The fruits were then reextracted using dichloromethane and methanol, respectively, following the methods described above.
Experimental
The separate extracts, on concentration, gave dichloromethane and methanol extract in yields of 1.16% and 4.47%, respectively.
The DCM fraction of E. umbelliflora leaves was partitioned using column chromatography on silica gel 60 (70-230 mesh) and elution with increasing concentrations of ethyl acetate in n-hexane to give 9 sub-fractions, which were then re-chromatographed under the same conditions yielding a mixture of αand β-amyrin (1), a mixture of betulin with betulinic acid (2), and taraxerol (3), as recently described [9a] . For the filamentous fungi, the inocula suspensions were obtained according to reported procedures and were adjusted to between 1.0 x 10 6 and 5.0 x 10 6 spores/mL by microscopic enumeration with a cell counting hemocytometer (Neubauer chamber) [9b]. The yeasts were prepared according to Pfaller et al.
Microorganisms and media:
[9c], where the suspension was adjusted spectrophotometrically to match the transmittance of a 0.5 McFarland standard at 530 nm. A cell suspension contained 1.0 x 10 6 to 5.0 x 10 6 organisms per mL.
Quantitative antifungal evaluation:
The minimum inhibitory concentration (MIC) of each extract, fraction or compound was determined using agar dilution techniques according to reported procedures [9d], with some modifications. The assay was carried out on slants (1 mL) against yeasts and filamentous fungi. Stock solutions of extracts, fractions and compounds were diluted with dimethylsulfoxide (DMSO)/water (1:1), and prepared as two-fold serial agar dilutions, for addition to sterile SDA medium in concentrations ranging from 100 to 1000 µg/mL. Afterwards, a volume of 1 µL of inoculum suspension (10 3 cells) was added to each slant, with the exception of the sterile control. The final concentration of DMSO in the assay did not exceed 2%, and the antifungal agent ketoconazole (Janssen Pharmaceutical) was included in the assay as a positive control. A drug-free solution was also used as a blank control. Each assay was repeated three times. The slants were incubated at 35ºC for the yeasts and at 28-30ºC for the hialohyphomycete and dermatophyte strains. The MICs were visually recorded after 48 h for the yeasts, and in accordance with control fungus growth for the rest of the fungi.
